Contact
QR code for the current URL

Story Box-ID: 142647

EvidentIQ Group GmbH Rathausmarkt 5 20095 Hamburg, Germany https://evidentiq.com
Contact Ms MSc Simone Hoerrlein +49 89 4522775230

XClinical invited to speak at two CDISC user group meetings in 2008

XClinical executives will be presenting at two important CDISC European User Group Meetings in January 2008

(PresseBox) (München, )
XClinical, an european vendor of innovative software products for e-clinical trials, today announced the invitation to two important industry events, the CDISC User Group Meetings in January 2008.

XClinical executives will discuss key issues regarding CDISC ODM (Operational Data Model) in clinical trials in presentations at two CDISC European User Group Meetings, to be held on January 21, 2008, in Paris, France, and in Copenhagen, Denmark. The presentations will focus on the benefits and use of CDISC data standards. CEO and Co-founder, Dr. Philippe Verplancke, who is a well-known ODM expert, will give an introduction regarding all aspects of ODM in clinical studies and the benefits of using ODM in managing the whole clinical trial process. Another XClinical executive team member will introduce CDISC ODM at the CDISC Nordic User Group Meeting which takes place in Copenhagen, Denmark, at the same date.

Dr. Verplancke has already spoken at the CDISC European Italian-Speaking User Group Meeting on November 16, 2007, in Milan, Italy. The objective of these user group meetings is to provide an effective exchange platform for users and potential users of the CDISC standards which are getting more and more important for the urgently needed standardization in clinical research.

XClinical is an active member of the CDISC organization (CDISC = Clinical Data Interchange Standards Consortium), and a CDISC ODM certified vendor of an innovative web-based platform that allows performing clinical trials electronically. XClinical’s software solutions are based on the CDISC data standards and cover the clinical data life cycle from end to end.

EvidentIQ Group GmbH

XClinical GmbH was founded in 2002, has its headquarters in Munich, Germany, and international offices in Paris, France, and Boston, USA. The company is a CDISC ODM certified vendor of MARVIN, a versatile, scalable, and flexible web-based EDC online platform for EDC (Electronic Data Capture), CDM and CTM based on the CDISC data standard ODM. XClinical offers companies involved in the clinical trial process MARVIN, and its excellent training and service solutions. For more information, please visit the company’s Web site at www.xclinical.com.

Simone Hoerrlein, XClinical GmbH, Tel.: +49 (0)89 / 45 22 77 – 52 30, Email: press@xclinical.com

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.